New: NCI-funded clinical trial search
Mednet Logo

Do you counsel patients differently about the risk of radiation induced malignancy when you are treating a proximal joint (hip) vs a distal joint (elbow) for benign conditions such as OA?

2 Answers
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC
Answered on

The mentality for this must change from radiation oncologist thinking to radiation medicine thinking. There have been no documented cases of malignancy from LDRT treatment of OA. Those who worry about the spine reference old studies giving 20 Gy in 5 fx with an open field pre-linac era. This is not comparable to what we are doing today with 3 Gy in 6 fx with 6MV linacs.

I've done some modeling in the past (I think on MedNet, perhaps?).

The problem is that if you estimate perhaps 5-50 mV of scatter for the elbow and maybe 25-250 mSV for the hip, the LNT may calculate somewhere between 1-12 excess cancers per 10k patients aged 70 and up. HOWEVER (I'm saying this loudly and waving my hands), this does not account for the fact that DNA repair a...

Join for free or sign in to see the full answer

Mednet Member
Radiation Oncology · Jacob E Locke MD PA
Answered on

Could not agree more.

Join for free or sign in to see the full answer